<?xml version="1.0" encoding="UTF-8"?> 
 <rss version="2.0">
 <channel>
  <title>Dr. Reddys  Press Releases</title> 
  <link>http://220.227.247.121/drreddys/v.9.4/newsroom/pressreleases.htm</link> 
  <description>Dr. Reddy's laboratories  Press Releases</description> 
 <image>
  <title> Dr. Reddys  Press Releases </title> 
  <width>142</width> 
  <height>42</height> 
  <link> http://220.227.247.121/drreddys/v.9.4/newsroom/pressreleases.htm /</link> 
  <url> http://220.227.247.121/drreddys/v.9.4/images/drreddys_logo.gif</url> 
  </image>
 <item>
  <title> Dr. Reddys is the First Participant in United States Pharmacopoeias New Pharmaceutical Ingredient Verification Programme   April 17, 2007</title> 
  <guid isPermaLink="false"></guid> 
  <link> http://www.drreddys.com/newsroom/popups/apr17_2007.htm </link> 
  <pubDate>Tue, 17 Apr 2007</pubDate> 
  </item>
 <item>
  <title>Dr. Reddy’s Q3 FY07 revenue at Rs 15,434 million; Net income at Rs 1,879 million; Nine Months Revenues cross USD 1 billion – January 22, 2007</title> 
  <guid isPermaLink="false"></guid> 
  <link>http://www.drreddys.com/newsroom/popups/jan22_2007.html</link> 
  <pubDate>Mon, 22 Jan 2007</pubDate> 
  </item>
 <item>
  <title>Dr. Reddy's Announces Final Approval of Ondansetron Tablets with 180 Days of Marketing Exclusivity 
December 27, 2006</title> 
  <guid isPermaLink="false"></guid> 
  <link>http://www.drreddys.com/newsroom/popups/ondansetron281206.htm</link> 
  <pubDate>Wed, 27 dec 2007</pubDate> 
  </item>
 <item>
  <title>Perlecan Pharma moves Dr. Reddy's novel antidiabetic drug candidate to Phase I clinical trial 
December 26, 2006</title> 
  <guid isPermaLink="false"></guid> 
  <link>http://www.drreddys.com/newsroom/popups/perlecan_dec271206.htm</link> 
  <pubDate>Wed, 27 dec 2007</pubDate> 
  </item>  
  </channel>
  </rss>